- Home
- ZBIO vs ATOM-USD Comparison
ZBIO vs ATOM-USD Comparison
Compare ZBIO & ATOM-USD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- ATOM-USD
- Stock Information
- Founded
- ZBIO 2019
- ATOM-USD N/A
- Country
- ZBIO United States
- ATOM-USD
- Employees
- ZBIO N/A
- ATOM-USD N/A
- Industry
- ZBIO
- ATOM-USD
- Sector
- ZBIO
- ATOM-USD
- Exchange
- ZBIO NYSE
- ATOM-USD
- Market Cap
- ZBIO 389.2M
- ATOM-USD N/A
- IPO Year
- ZBIO 2024
- ATOM-USD N/A
- Fundamental
- Price
- ZBIO $9.65
- ATOM-USD $4.13
- Analyst Decision
- ZBIO Strong Buy
- ATOM-USD
- Analyst Count
- ZBIO 7
- ATOM-USD 0
- Target Price
- ZBIO $32.29
- ATOM-USD N/A
- AVG Volume (30 Days)
- ZBIO 217.6K
- ATOM-USD N/A
- Earning Date
- ZBIO 08-16-2025
- ATOM-USD N/A
- Dividend Yield
- ZBIO N/A
- ATOM-USD N/A
- EPS Growth
- ZBIO N/A
- ATOM-USD N/A
- EPS
- ZBIO N/A
- ATOM-USD N/A
- Revenue
- ZBIO $15,000,000.00
- ATOM-USD N/A
- Revenue This Year
- ZBIO $206.00
- ATOM-USD N/A
- Revenue Next Year
- ZBIO $41.92
- ATOM-USD N/A
- P/E Ratio
- ZBIO N/A
- ATOM-USD N/A
- Revenue Growth
- ZBIO N/A
- ATOM-USD N/A
- 52 Week Low
- ZBIO $5.83
- ATOM-USD N/A
- 52 Week High
- ZBIO $26.25
- ATOM-USD N/A
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- ATOM-USD 51.06
- Support Level
- ZBIO N/A
- ATOM-USD $3.85
- Resistance Level
- ZBIO N/A
- ATOM-USD $4.14
- Average True Range (ATR)
- ZBIO 0.00
- ATOM-USD 0.19
- MACD
- ZBIO 0.00
- ATOM-USD 0.04
- Stochastic Oscillator
- ZBIO 0.00
- ATOM-USD 91.79
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.